Target
HMG-CoA reductase
2 products, 2 indications
Indications
cardiovascular disease prevention (2 products)
atherosclerosis (2 products)
Loading...
1 drug
9 abstracts
Abstract
Randomized, placebo-controlled trial of atorvastatin to prevent hearing loss in patients with head and neck squamous cell carcinoma receiving cisplatin based chemoradiation (CRT).Org: NIDCD/NIH, National Center for Rehabilitative Auditory Research, NIH/NHLBI, NIH/NIDCD,
Abstract
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Secondary analysis of the SPARTAN trial.Org: Division of Urology and Surgical Oncology, Guy's, King's, and St. Thomas' Hospitals,
Abstract
Effect of antibiotic, proton pump inhibitor, H2 blocker, metformin and statin use on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting.Org: John D. Dingell VA Hospital,
Abstract
Impact of commonly prescribed medications on immune-related adverse events.Org: Veterans Affairs Ann Arbor Healthcare System,
Abstract
Adherence to statins and risk of cardiovascular disease in patients with breast cancer.Org: Division of Research Services, Kaiser Permanente Northern California, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center,
Abstract
The timing of statin initiation on survival outcomes of cancer patients treated with immune checkpoint inhibitors: A retrospective cohort study.Org: Unity Hospital, Rochester Regional Health System, Department of Medical Education, Kuang Tien General Hospital, Mount Auburn Hospital,
Abstract
Statin use for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in breast cancer (BC) patients (pts).Org: Tufts Medical Center/Tufts University, Tufts University School of Medicine,
Abstract
A retrospective single-centre analysis of the prevalence of statin use in geriatric oncology: Is there a role for cessation?Org: Health Services Executive, Ireland, University Hospital Waterford, Waterford, Health Service Executive,
Abstract
Cardiovascular comorbidities and cardiovascular events in patients with metastatic prostate cancer.Org: Laboratoire Toxicomed, University of Tlemcen, Tidjani Damerdji Teaching Hospital, CHU Tlemcen,
Drug
Rosuvastatin